- Home
- THTX vs SGMO Comparison
THTX vs SGMO Comparison
Compare THTX & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THTX
- SGMO
- Stock Information
- Founded
- THTX 1993
- SGMO 1995
- Country
- THTX Canada
- SGMO United States
- Employees
- THTX N/A
- SGMO N/A
- Industry
- THTX Biotechnology: Pharmaceutical Preparations
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- THTX Health Care
- SGMO Health Care
- Exchange
- THTX Nasdaq
- SGMO Nasdaq
- Market Cap
- THTX 119.1M
- SGMO 122.8M
- IPO Year
- THTX N/A
- SGMO 2000
- Fundamental
- Price
- THTX $2.53
- SGMO $0.46
- Analyst Decision
- THTX Hold
- SGMO Buy
- Analyst Count
- THTX 1
- SGMO 6
- Target Price
- THTX N/A
- SGMO $4.50
- AVG Volume (30 Days)
- THTX 139.5K
- SGMO 4.1M
- Earning Date
- THTX 07-09-2025
- SGMO 08-05-2025
- Dividend Yield
- THTX N/A
- SGMO N/A
- EPS Growth
- THTX N/A
- SGMO N/A
- EPS
- THTX N/A
- SGMO N/A
- Revenue
- THTX $88,666,000.00
- SGMO $63,756,000.00
- Revenue This Year
- THTX N/A
- SGMO N/A
- Revenue Next Year
- THTX $15.13
- SGMO N/A
- P/E Ratio
- THTX N/A
- SGMO N/A
- Revenue Growth
- THTX 13.52
- SGMO 239.92
- 52 Week Low
- THTX $1.12
- SGMO $0.30
- 52 Week High
- THTX $3.13
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- THTX 49.00
- SGMO 38.27
- Support Level
- THTX $2.38
- SGMO $0.49
- Resistance Level
- THTX $2.68
- SGMO $0.51
- Average True Range (ATR)
- THTX 0.09
- SGMO 0.04
- MACD
- THTX -0.02
- SGMO 0.01
- Stochastic Oscillator
- THTX 51.72
- SGMO 6.25
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.